IP Library › Granted Patent US 7,514,473
Granted Patent B2
US 7,514,473 · App. 10/536,416 · Granted Apr 7, 2009

Calcilytic compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,514,473
App. No.
10/536,416
Granted
Apr 7, 2009
Kind
B2
Abstract

Novel Calcilytic compounds and methods of using them are provided.

Claims (6)

1. The compound 3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-propionic acid hydrochloride.

2. A pharmaceutical composition comprising the compound of claim 1 and pharmaceutically acceptable diluent or excipient.

3. The compound 3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-propionic acid.

4. A pharmaceutical composition comprising the compound of claim 3 and a pharmaceutically acceptable diluent or excipient.

5. A pharmaceutically acceptable salt of the compound 3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-propionic acid.

6. A pharmaceutical composition comprising the compound of claim 5 and a pharmaceutically acceptable diluent or excipient.

Assignments (2)
CHANGE OF NAME Recorded Jan 6, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023731/0761 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2005
From: CASILLAS, LINDA N; MARQUIS, ROBERT W; RAMANJULU, JOSHI M; CALLAHAN, JAMES FRANCIS
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 016589/0937 →